Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial

Hypertension - United States
doi 10.1161/01.hyp.37.1.12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Baseline Characteristics of African Americans in the Systolic Blood Pressure Intervention Trial

Journal of the American Society of Hypertension
Internal MedicineCardiovascular MedicineCardiology
2015English

PS1-04: Home Blood Pressure Telemonitoring and Case Management to Control Hypertension: HyperLink Trial Design and Baseline Characteristics

Clinical Medicine and Research
MedicineHome CareCommunity
2010English

Patient Characteristics Associated With Greater Blood Pressure Control in a Randomized Trial of Home Blood Pressure Telemonitoring and Pharmacist Management

Journal of the American Society of Hypertension
Internal MedicineCardiovascular MedicineCardiology
2016English

The Appropriate Blood Pressure Control in Diabetes (ABCD) Trial

Journal of Human Hypertension
Internal Medicine
1998English

Blood Pressure Control in the Hypertension in the Very Elderly Trial (HYVET)

Journal of Human Hypertension
Internal Medicine
2011English

Characteristics Associated With Antihypertensive Treatment and Blood Pressure Control

Global Heart
EpidemiologyCardiovascular MedicineHome CareCommunityCardiology
2016English

Baseline Characteristics in the VERIFY Study: A Randomized Trial Assessing the Durability of Glycaemic Control With Early Vildagliptin-Metformin Combination in Newly Diagnosed Type 2 Diabetes

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Impact of Baseline Systolic Blood Pressure on Visit-To-Visit Blood Pressure Variability: The Kailuan Study

Therapeutics and Clinical Risk Management
2016English

Gender and Blood Pressure Control

Hypertension
Internal Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy